Symptom Frequency and Persistence in the First Year After Traumatic Brain Injury: A TRACK-TBI Study
Overview
Neurology
Authors
Affiliations
Symptom endorsement after traumatic brain injury (TBI) is common acutely post-injury and is associated with other adverse outcomes. Prevalence of persistent symptoms has been debated, especially in mild TBI (mTBI). A cohort of participants ≥17 years with TBI ( = 2039), 257 orthopedic trauma controls (OTCs), and 300 friend controls (FCs) were enrolled in the TRACK-TBI study and evaluated at 2 weeks and 3, 6, and 12 months post-injury using the Rivermead Post-Concussion Symptoms Questionnaire (RPQ). TBI participants had significantly higher symptom burden than OTCs or FCs at all times, with average scores more than double. TBI cases showed significant decreases in RPQ score between each evaluation ( < 0.001), decreasing ∼1.7 points per month between 2 weeks and 3 months and 0.2 points per month after that. More than 50% of the TBI sample, including >50% of each of the mild and moderate/severe TBI subsamples, continued to endorse three or more symptoms as worse than pre-injury through 12 months post-injury. A majority of TBI participants who endorsed a symptom at 3 months or later did so at the next evaluation as well. Contrary to reviews that report symptom resolution by 3 months post-injury among those with mTBI, this study of participants treated at level 1 trauma centers and having a computed tomography ordered found that persistent symptoms are common to at least a year after TBI. Additionally, although symptom endorsement was not specific to TBI given that they were also reported by OTC and FC participants, TBI participants endorsed over twice the symptom burden compared with the other groups.
A double-blind randomized trial of hyperbaric oxygen for persistent symptoms after brain injury.
Weaver L, Ziemnik R, Deru K, Russo A Sci Rep. 2025; 15(1):6885.
PMID: 40011516 PMC: 11865602. DOI: 10.1038/s41598-025-86631-6.
Faulkner J, Prouty D, Devlin L, Appleton D, Roche M, Below K BMJ Open. 2025; 15(2):e089727.
PMID: 39956598 PMC: 11831269. DOI: 10.1136/bmjopen-2024-089727.
Hovset C, Roe C, Soberg H, Brunborg C, Helseth E, Andelic N J Rehabil Med. 2024; 56:jrm35115.
PMID: 39539069 PMC: 11577624. DOI: 10.2340/jrm.v56.35115.
Rioux M, Mamman R, Byworth M, Panenka W, Howard A, Perez D BMJ Neurol Open. 2024; 6(2):e000666.
PMID: 39410977 PMC: 11474702. DOI: 10.1136/bmjno-2024-000666.
Zhuo J, Raghavan P, Li J, Roys S, Tchoquessi R, Chen H Front Neurol. 2024; 15:1443496.
PMID: 39170078 PMC: 11335690. DOI: 10.3389/fneur.2024.1443496.